Form D Explorer

Inspect source fieldsReport a record issue

Form D/A — Linnaeus Therapeutics, Inc.

0001752026-26-000006 · filed Mar 31, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
Rule 506(b)
Reported offering amount
$10,000,000
Reported amount sold
$4,892,000
Minimum investment
$1
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Linnaeus Therapeutics, Inc.
CIK
1752026
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
30 WASHINGTON AVENUE, SUITE F
HADDONFIELD, New Jersey 08033
Phone
856-433-1500

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗